Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K/AKT/mTOR pathway.

Liu, Ning; Yan, Limei; Shan, Fengping; Wang, Xiaonai; Qu, Na; Handley, Mike K; Ma, Mingxing.

Affiliation

Liu N; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang 110004, Liaoning, China.
Yan L; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang 110004, Liaoning, China.
Shan F; Department of Immunology, College of Basic Medical Science, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning, China.
Wang X; Department of Immunology, College of Basic Medical Science, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning, China.
Qu N; Department of Gynecology, Cancer hospital of China Medical University, Liaoning Cancer Hospital & Institute, No. 44, Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning, China.
Handley MK; Cytocom Inc., 37 North Orange Avenue, Suite 607, Orlando, FL 32801, USA.
Ma M; Department of General Surgery, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang 110004, Liaoning, China. Electronic address: mamx66@126.com.

Transl Oncol ; 14(4): 101028, 2021 Apr.

Article in En | MEDLINE | ID: mdl-33540155